This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Veronica Zeng, Ph.D.
Principal Scientist, Discovery Biology & Pharmacol at Xencor, Inc.

Agenda Sessions

  • Tumor-Targeted CD28 Bispecific Antibodies Costimulate T Cells in the Tumor Microenvironment